News and Comments

New Development in Amgen offer To Acquire Onyx

  Sunday, June 30, 2013

In a new development, Onyx (ONXX) confirmed Amgen’s offer in the same release that announced rejecting it. Indeed, Onyx has rejected Amgen’s unsolicited proposal that suggests acquiring Onyx’s outstanding shares and share equivalents for $120 per share in cash, subject to due diligence and other conditions.  More...

ONYX TAKEOVER WAS EXPECTED

  Sunday, June 30, 2013

In November 2011 Prohost posted an article titled “Deal or no deal, time for a payoff” (click HERE to read the article). All that prophesized in that article about Onyx’ (ONXX) drugs and prospects has materialized and the final item, a takeover, seems to be on the verge of happening.   More...

Two Small Great Biotechs Underestimated by the Market

  Tuesday, June 25, 2013

Seattle Genetics’ (SGEN) and ImmunoGen’s (IMGN) conjugated monoclonal antibody therapeutics for cancer are increasingly validating their superior safety and efficacy over other cancer products that are used without the antibody drug conjugates (ADC).  More...

Why Amgen and Cytokinetics Agreement is Good News?

  Wednesday, June 12, 2013

NEWS WE WERE WAITING FOR More...


Recent Postings


Archive


Tags

Global Cell Therapeutics (GBT) ARGOS (ARGS) Ridaforolimus Revlimid (lenolidamide) Telaprevir Merck (MRK) ADVENTRIX (ANX) JUNO (JUNO) RenenxBio (RGNX) Dendreon (DNDN) Vertex (VRTX) Anadys (ANDS) Vitae Pharmaceuticals (VTAE) Benlysta (belimumab) Velcade (bortezomib) C4 Therapeutics Array Pharmaceuticals (ARRY) IDERA (IDRA) Adaptimmune (ADAP) Ziofpharm (ZIOP) VANDA (VNDA) Regeneron (REGN) Prosensa (RNA) GlaxoSmithKline (GSK) AGOS (ARGS) Anacor (ANAC) Amgen (AMGN) Alnylam (ALNY) Prolor Biotech (PBTH) Abbott Laboratories (ABT) Illumina (ILMN) Gilead (GILD) Pluristem (PSTI) AstraZeneca (AZN) Zerenex Ariad (ARIA) Theravance (THRX) ImmunoGen (IMGN) NEKTAR (NKTR)) Exelixis (EXEL) HALOZYME (HALO) Editas (EDIT) PTC Therapeutics (PTCT) Biogen Idec (BIIB) Micromet (MITI) Jazz Pharmaceuticals (JAZZ) Genentech Xoma (XOMA) Alder Biopharmaceuticals (ALDR) SYNTA (SNTA) Theravance Bio Pharma (TBPH) NOVOCURE (NVCR) Spike Therapeutics (ONCE) Roche (RHHBY) ZALTRAP™ SERES THERAPEUTICS (MCRB) galapagos (GLPG) ACADIA (ACAD) Intermune (ITMN) Human Longevity (HLI) Cytokinetics (CYTK) Biocryst (BCRX) ISIS (ISIS) Elan (ELN) Multiple Myeloma Galena (GALE) NANTKWEST (NK) REGULUS (RGLS) Bristol-Myers Squibb (BMY) INNOVIVA (INVA) Endometrial Cancer Aimmune Therapeutics (AIMT) Ionis (IONS) KITE (KITE) Roche (ROCHE) OSI (OSIP) Human Genome Sciences (HGSI) Idenix (IDIX) Auspex (ASPX) Intercept (ICPT) Mirati Therapeutics (MRTX) SUNESIS PHARMACEUTICALS (SNSS) Incyte (INCY) CompuGen (CGEN) Sequenom (SQNM) Sanofi (SNY) Valeant Pharmaceuticals International (VRX) Rapamune Sanofi-Aventis (SAN) Bellicum (BLCM) Inovio (INO) KERYX (KERX) MODERNA Sanofi (SNA) ABBVIE (ABBV) Intrexon (XON) ARCA (ABIO) Advaxis (ADXS) Agenus (AGEN) Trastuzumab-DM1 BIOMARIN (BMRN) Sarepta (SRPT) Onyx (ONXX) Dynavax (DVAX) Sangamo (SGMO) Tysabri Seattle Genetics (SGEN) Agenus (AGEN GUARDIAN HEALTH Herceptin TOKAI (TKAOI) AERIE PHARMACEUTICALS